You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The Bay Area firm has built on its enzymatic barcoding technology to deliver a high-throughput, synthetic long-read library preparation technique.
Nature News reports that cloning researcher Li Ning has been sentenced to 12 years in jail for embezzling research funds.
The synthetic biology and DNA data storage firm will use the funds to launch its BioXp 3200 automated gene synthesis and cloning platform.
Agence France-Presse reports that the Chinese firm Sinogene has successfully cloned a pet cat.
Chinese researchers have used somatic cell nuclear transfer to clone two monkeys, called Zhong Zhong and Hua Hua.
The approach, published earlier this week in Nature Biomedical Engineering, uses long-adapter single-strand oligonucleotide (LASSO) probes.
In a series of articles, Scientific American looks at the 20 years since Dolly the Sheep was cloned.
The programmable nuclease can replace restriction enzymes, enables cloning of large genomic sequences, and can deplete unwanted DNA species.
Agilent will offer its SureVector cloning kits through Eurofins and will supply components for cloning services performed by Eurofins.
While one researcher says cloning the mammoth may be decades away, if successful, it may lead to a theme park of species that would no longer be extinct.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.